When overexpressed or activated in mice fed sirtuin-activating compounds (STACs), Sirt1 also prevents obesity, improves energy balance, insulin-sensitivity and glucose tolerance, limits the damaging effects of fatty foods and delays ageing [4–7]. Here, SIRT1 is linked to obesity disorder.